Try our Advanced Search for more refined results
Health - March, 2005
24 articles
- Judge Rejects Antitrust Challenge To Hatch-Waxman Settlement
- Barr, Kos Pharma In Talks To Settle Niaspan Patent Litigation
- Judge Doubles Damages In Applera Patent Suit Vs. MJ Research
- Pfizer Sees Decision In Viagra Patent Case In 1-3 Months
- Ranbaxy, Teva To Appeal Injunction Against Accupril Generics
- Teva, Mylan Get FDA OK For Zyprexa Generic
- Pfizer Wins Preliminary Injunction Vs. Teva, Ranbaxy In Accupril Suit
- Austria Strips Pfizer Of Lipitor Patent
- J&J Wins Jury Verdict Vs. Boston Scientific In Patent Suit Over Drug-Coated Stent
- India's Upper House Passes Patents Act Amendment
- Sanofi-Aventis Fights Off Plavix Patent Challenge In Canada
- Hatch To Head Senate IP Panel
- Jury Orders Mary Kay To Pay TriStrata $26.4M In Patent Dispute Over Wrinkle Treatment
- Brazil Threatens U.S. AIDS Drug Makers With Compulsory Licensing
- Medtronic Loses Another Jury Trial Over Stent Patents
- Bausch & Lomb Withdraws Patent Suit Vs. Inverness
- India's Government Introduces Amendment To Patents Act
- Biovail Sues Impax Over Wellbutrin XL Patent
- Kos Seeks Court Order to Block Launch of Generic Niaspan
- Appeals Court Overturns FTC Order On Settlements Of Drug Patent Disputes
- European Patent Office Backs AstraZeneca's Symbicort Patent
- Bausch & Lomb Sues Again Over Eye Vitamin Patent
- Umbilical-Cord Blood Storage Patents Challenged
- Waxman Vows To Fight Bill That Would Extend Drug Patents, Data Exclusivity